Lee Chun Park
About
Lee Chun Park is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine.
According to data from OpenAlex, Lee Chun Park has authored 30 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Lee Chun Park's work include Lymphoma Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Lee Chun Park is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Lee Chun Park collaborates with scholars based in South Korea, United States and Singapore. Lee Chun Park's co-authors include Jun Ho Ji, Won Seog Kim, Seok Jin Kim, Seong Hoon Shin, Joon Young Choi, Seonwoo Kim, Seung Hwan Moon, Yang Soo Kim, Ho Sup Lee and Myung‐Ju Ahn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
In The Last Decade
Lee Chun Park
30 papers receiving 370 citations
Peers
Lee Chun Park
Ανδρέας Κουρέας Greece
Burkhard Otremba Germany
Ghandi Damaj France
Ji Hyun Lee South Korea
Alberto Agazzi Italy
Laurence Venat‐Bouvet France
Kezban Nur Pilancı Türkiye
Diana Almader‐Douglas United States
Xiaoli Zhu China
C. Rusconi Italy
Citations per year, relative to Lee Chun Park Lee Chun Park (= 1×)
peers
Ανδρέας Κουρέας
Countries citing papers authored by Lee Chun Park
Since
Specialization
Citations
This map shows the geographic impact of Lee Chun Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Chun Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Chun Park more than expected).
Fields of papers citing papers by Lee Chun Park
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Lee Chun Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Chun Park. The network helps show where Lee Chun Park may publish in the future.
Co-authorship network of co-authors of Lee Chun Park
This figure shows the co-authorship network connecting the top 25 collaborators of Lee Chun Park. A scholar is included among the top collaborators of Lee Chun Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Chun Park. Lee Chun Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lee, Jiyun, Sehhoon Park, Hyun Ae Jung, et al.. (2023). A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas. Cancer. 129(19). 2966–2974.
2.
Seo, Seyoung, Bhumsuk Keam, Seong Hoon Shin, et al.. (2023). A phase Ia/Ib study of novel anti‐ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer. International Journal of Cancer. 153(8). 1501–1511.
3.
Chae, Young Kwang, Andrew A. Davis, Lee Chun Park, et al.. (2020). Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy. Translational Lung Cancer Research. 9(4). 1015–1028.
4.
Park, Lee Chun, Minjung Kim, Jae‐Cheol Jo, et al.. (2019). The effects of erythropoiesis‐stimulating agents on the management of chemotherapy‐induced anemia and tumor growth in diffuse large B‐cell lymphoma patients. International Journal of Cancer. 145(9). 2459–2467.
5.
Chae, Young Kwang, et al.. (2019). Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review. BMC Cancer. 19(1). 748–748.
6.
Chae, Young Kwang, et al.. (2018). Abstract 4608: Immunologic and clinical implications of harboring mutations in mismatch repair (MMR) genes in non-small cell lung cancer (NSCLC). Cancer Research. 78(13_Supplement). 4608–4608.
7.
Park, Lee Chun, Jonathan F. Anker, Michael S. Oh, et al.. (2018). Immunologic and clinical implications of CD73 expression in non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 36(15_suppl). 12050–12050.
8.
Kim, Moon Jin, Young Sam Kim, Sung Yong Oh, et al.. (2016). Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee. The Korean Journal of Internal Medicine. 33(2). 383–390.
9.
Park, Lee Chun, Ji Yun Jeong, Jun Ho Ji, et al.. (2014). Intra-tumoral Metastatic Double Primary Carcinoma: Synchronous Metastatic Tumor in Lung from Breast and Thyroid Carcinoma. Cancer Research and Treatment. 46(2). 200–203.
10.
Lee, Ho Sup, Lee Chun Park, Eun Mi Lee, et al.. (2013). Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemia. Annals of Hematology. 92(12). 1685–1693.
11.
Moon, Seung Hwan, Lee Chun Park, Jun Ho Ji, et al.. (2013). Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 40(7). 1005–1013.
12.
Lee, Ho Sup, Lee Chun Park, Eun Mi Lee, et al.. (2013). The Prognostic Significance of Elevated Levels of Serum Ferritin Before Chemotherapy in Patients With Non-Hodgkin Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 14(1). 43–49.
13.
Park, Lee Chun, Sook‐Young Woo, Seonwoo Kim, et al.. (2012). Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: Results from a prospective cohort study with Asian population. Thrombosis Research. 130(3). e6–e12.
14.
Park, Silvia, Seung Hwan Moon, Lee Chun Park, et al.. (2012). The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma. American Journal of Hematology. 87(9). 937–940.
15.
Park, Lee Chun, Jun Ho Ji, Silvia Park, et al.. (2012). Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutation. Cancer Chemotherapy and Pharmacology. 70(2). 315–320.
16.
Lee, Ho Sup, Lee Chun Park, Eun Mi Lee, et al.. (2012). Comparison of Therapeutic Outcomes Between Surgical Resection Followed By R-CHOP and R-CHOP Alone for Localized Primary Intestinal Diffuse Large B-cell Lymphoma. American Journal of Clinical Oncology. 37(2). 182–187.
17.
Park, Silvia, Hee Kyung Ahn, Lee Chun Park, et al.. (2012). Implications of Different CA 15-3 Levels according to Breast Cancer Subtype at Initial Diagnosis of Recurrent or Metastatic Breast Cancer. Oncology. 82(3). 180–187.
18.
Park, Lee Chun. (2012). Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer. World Journal of Gastroenterology. 18(10). 1104–1104.
19.
Lee, Ho Sup, Lee Chun Park, Eun Mi Lee, et al.. (2011). Incidence Rates and Risk Factors for Vascular Events in Patients With Essential Thrombocythemia: A Multicenter Study From Korea. Clinical Lymphoma Myeloma & Leukemia. 12(1). 70–75.
20.
Park, Lee Chun, Ho Sup Lee, Seong Hoon Shin, et al.. (2011). Herpesviridae Viral Infections following Rituximab Combined Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma. Acta Haematologica. 125(4). 230–236.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ανδρέας Κουρέας Breakdown of academic impact, for papers by Burkhard Otremba Breakdown of academic impact, for papers by Ghandi Damaj Breakdown of academic impact, for papers by Ji Hyun Lee Breakdown of academic impact, for papers by Alberto Agazzi Breakdown of academic impact, for papers by Laurence Venat‐Bouvet Breakdown of academic impact, for papers by Kezban Nur Pilancı Breakdown of academic impact, for papers by Diana Almader‐Douglas Breakdown of academic impact, for papers by Xiaoli Zhu Breakdown of academic impact, for papers by C. Rusconi